Biohaven (BHVN) Change in Acquisitions & Divestments (2023 - 2026)
Biohaven's (BHVN) quarterly Change in Acquisitions & Divestments came in at $35.0 million in Q1 2026, down 83.33% year-on-year from $210.0 million in Q1 2025, and up 107.07% quarter-over-quarter from -$495.0 million in Q4 2025.
Biohaven (BHVN) Change in Acquisitions & Divestments (2023 - 2026) Analysis & Trends
Biohaven has disclosed Change in Acquisitions & Divestments across 4 years of filings, most recently posting $35.0 million for Q1 2026.
- Change in Acquisitions & Divestments for Q1 2026 came in at $35.0 million, down 83.33% year-over-year; the trailing twelve-month figure through Mar 2026 was -$175.0 million (down 143.53% YoY), and the FY2024 annual result was $504.4 million, up 56.6% from the prior year.
- Change in Acquisitions & Divestments came in at $35.0 million for Q1 2026 at Biohaven, up from -$495.0 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $317.2 million in Q4 2023 to a low of -$495.0 million in Q4 2025.
- The 4-year median for Change in Acquisitions & Divestments is $100.6 million (2024), against an average of $65.5 million.
- Across the five-year window, Change in Acquisitions & Divestments surged 200.61% in 2024 and slumped 357.81% in 2025, its largest moves.
- Biohaven's Change in Acquisitions & Divestments stood at $317.2 million in 2023, then sank by 39.46% to $192.0 million in 2024, then plunged by 357.81% to -$495.0 million in 2025, then jumped by 107.07% to $35.0 million in 2026.
- The last three Change in Acquisitions & Divestments figures came in at $35.0 million (Q1 2026), -$495.0 million (Q4 2025), and $165.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Biohaven | 1.62 Bn | 1.27 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.00 Mn |
| Mar 31, 2026 | 35.00 Mn |
| Dec 31, 2025 | -495.00 Mn |
| Dec 31, 2025 | -495.00 Mn |
| Sep 30, 2025 | 165.00 Mn |
| Sep 30, 2025 | 165.00 Mn |
| Jun 30, 2025 | 120.00 Mn |
| Jun 30, 2025 | 120.00 Mn |
| Mar 31, 2025 | 210.00 Mn |
| Mar 31, 2025 | 210.00 Mn |
| Dec 31, 2024 | 192.00 Mn |
| Dec 31, 2024 | 192.00 Mn |
| Mar 31, 2024 | 81.16 Mn |
| Mar 31, 2024 | 81.16 Mn |
| Dec 31, 2023 | 317.16 Mn |
| Dec 31, 2023 | 317.16 Mn |
| Jun 30, 2023 | 2.46 Mn |
| Jun 30, 2023 | 2.46 Mn |
| Mar 31, 2023 | 27.00 Mn |
| Mar 31, 2023 | 27.00 Mn |